# US 2023/0265384 A1 · Adult stem cell compositions and methods of identification and isolation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265384 A1
- Document ID: US20230265384A1
- Status: Published application
- Kind: A1
- Application number: 18/088,683
- Filed: 2022-12-26
- Published: 2023-08-24
- Earliest claimed: 2015-08-28
- Assignees: TACS Bio Inc.
- Applicants: Tacs Bio, Inc.
- Inventors: Keith D. Crawford; Baldev Vasir; John Garvey
- Web page: https://patentgrep.com/patent/US20230265384A1

## CPC

- A61K 35/545: Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
- C12N 5/0607: {Non-embryonic pluripotent stem cells, e.g. MASC (induced pluripotent stem cells C12N5/0696)}
- C12N 5/0668: {Mesenchymal stem cells from other natural sources}
- C12N 15/79: Vectors or expression systems specially adapted for eukaryotic hosts
- G01N 33/53: Immunoassay; Biospecific binding assay; Materials therefor
- G01N 33/56972: {White blood cells}
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2501/58: Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
- C12N 2501/599: with CD designations not provided for elsewhere
- C12N 2506/00: Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- G01N 33/56966: {Animal cells}
- G01N 2333/4725: Mucins, e.g. human intestinal mucin
- G01N 2333/70525: ICAM molecules, e.g. CD50, CD54, CD102
- G01N 2333/70596: Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
- G01N 2400/24: beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Methods, compositions and cells are provided that identify and isolate a population of adult non-embryonic progenitor cells having multilineage potential, physical diameters of about 2 μm to about 8 μm in size or about 4 μm to about 6 μm, and expressing at least one of the stem cell associated genes among Oct-4, KLF-4, Nanog, Sox-2, Rex-1, GDF-3 or Stella. Methods are also provided that identify and isolate populations, which are subsets or subpopulations of progenitor adult stem cells within the population of the adult stem cells which is a heterogeneous population, the methods including contacting the adult stem cells with a ligand specific for at least one of: CD99, tetraspan, ICAM4, full-length MUC1, and truncated MUC1 receptor, in which a presence of a surface protein on the cells that bind to the ligand identifies the population which is the subset of the differentiated progenitor adult stem cells.

## Claims

### Claim 1

A method for identifying a population of progenitor cells, the method comprising:
obtaining from a sample tissue or fluid, a population of somatic cells including subpopulations of progenitor cells,
enriching at least one progenitor cell subpopulation relative to the somatic cells, said enriching further comprising selecting cell subpopulations having physical diameters of about 4 μm to about 6 μm in size,
assaying the enriched progenitor cell subpopulation for expression of one or more of stem cell associated genes Oct-4, KLF-4, Nanog, Sox-2, Rex-1, GDF-3 or Stella, whereby statistically significant expression of stem cell associated genes is predictive of a subpopulation having multilineage potential, and
identifying the subpopulation as a progenitor cell population based on gene expression.

### Claim 2 (depends on 1)

The method according to claim 1, further comprising identifying a cell surface polypeptide or peptidoglycan on cells within a progenitor cell subpopulation thereby identifying the subpopulation as having multilineage potential.

### Claim 3 (depends on 1)

The method according to claim 1, further comprising detecting on cell surface within the progenitor cell subpopulation, the presence of one or more surface antigens including CD99, tetraspan, ICAM, and a Mucin, e.g., MUC1 and its isoforms, CD11b, CD13, CD14, CD29, CD34, CD44, CD45, CD49a, CD49b, CD49c, CD49d, CD49e, CD49f, CD51, CD73, CD90, CD105, CD106, CD166, Oct-4, KLF-4, MHC class I, MHC class II and StrO1.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the MUC1 isoform has a truncated MUC1 receptor region, and detection of this isoform further identifies the progenitor cell subpopulation as having multilineage potential.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the truncated MUC1 receptor is MUC1 growth Factor Receptor (MGFR) comprising an amino acid sequence of a primary sequence of the MUC1 Growth Factor Receptor (PSMGFR).

### Claim 6 (depends on 3)

The method according to claim 3, wherein the cell surface antigen is a member of ICAM family of molecules.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the ICAM is ICAM 4 or ICAM5.

### Claim 8 (depends on 2)

The method of claim 2, wherein identifying the cell surface polypeptide or peptidoglycan is determined by proteomic analysis.

### Claim 9 (depends on 1)

The method of claim 1, further comprising obtaining and correlating tissue-specific gene expression information, microRNA analyses and/or proteomic information to determine a tissue differentiation potential for the subpopulation.

### Claim 10 (depends on 9)

The method according to claim 9 further comprising expanding the progenitor cell subpopulation and determining tissue differentiation potential.

### Claim 11 (depends on 10)

The method according to claim 10 further comprising inducing lineage differentiation during expansion and determining tissue differentiation potential.

### Claim 12 (depends on 11)

The method according to claim 11, wherein mesodermal lineage differentiation is induced.

### Claim 13 (depends on 11)

The method according to claim 11, wherein endodermal lineage differentiation is induced.

### Claim 14 (depends on 11)

The method according to claim 11, wherein ectodermal lineage differentiation is induced.

### Claim at position 15

15-28. (canceled)

### Claim 29

A method of identifying and isolating a population, which is a subset of adult stem cells within a heterogeneous pool of the adult stem cells, the method comprising,
contacting the adult stem cells with a ligand specific for at least one of: CD99, tetraspan, ICAM4, full-length MUC1, and truncated MUC1 receptor, wherein a presence of the ligand identifies the population which is the subset of the adult stem cells.

### Claim 30 (depends on 29)

The method of identifying and isolating a population according to claim 29,
wherein contacting the adult stem cells with the ligand and presence of the ligand attached to the cells identifies the population which is the subset of the primitive adult stem cells having the pluripotency properties.

### Claim at position 18

31-32. (canceled)

### Claim 33

A method for identifying a population of progenitor cells, the method comprising:
obtaining from a sample tissue or fluid, a population of somatic cells including subpopulations of progenitor cells,
enriching at least one progenitor cell subpopulation relative to the somatic cells, said enriching further comprising selecting cell subpopulations having physical diameters of about 2 μm to about 8 μm in size,
assaying the enriched progenitor cell subpopulation for expression of one or more of stem cell associated genes Oct-4, KLF-4, Nanog, Sox-2, Rex-1, GDF-3 or Stella, whereby statistically significant expression of stem cell associated genes is predictive of a subpopulation having multilineage potential, and
identifying the subpopulation as a progenitor cell population based on gene expression.

### Claim 34 (depends on 1)

A population of isolated human progenitor cells obtained according to the method described in claim 1.
